Signaling Networks and Cell Cycle Control

The Molecular Basis of Cancer and Other Diseases
2000. Auflage 2000
ISBN: 978-0-89603-710-6
Verlag: Humana Press

Buch, Englisch, 578 Seiten, Format (B × H): 178 mm x 254 mm, Gewicht: 1243 g

Reihe: Cancer Drug Discovery and Development

Leading scientists summarize the latest findings on signal transduction and cell cycle regulation and describe the effort to design and synthesize inhibiting molecules, as well as to evaluate their biochemical and biological activities. They review the relevant cell surface receptors, their ligands, and their downstream pathways. Also examined are the latest findings on the components of novel signaling networks controlling the activity of nuclear transcription factors and cell cycle regulatory molecules. Cutting-edge and highly suggestive, Signaling Networks and Cell Cycle Control: The Molecular Basis of Cancer and Other Diseases presents a wealth of information on the emerging principles of the field, as well as an invaluable guide for all experimental and clinical investigators of cell regulation and its rapidly emerging pharmacological opportunities today.

Zielgruppe

Research

Autoren/Hrsg.

Gutkind, J Silvio

Fachgebiete

• Naturwissenschaften Biowissenschaften Molekularbiologie
• Naturwissenschaften Biowissenschaften Proteinforschung
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Bildgebende Verfahren, Nuklearmedizin, Strahlentherapie Nuklearmedizin, PET, Radiotherapie
• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Kosmetische Technologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Biomedizin, Medizinische Forschung, Klinische Studien
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Physiologie

Inhaltsverzeichnis

1 Integrin Signaling.- 2 Signal Transduction Through Tyrosine Kinase Growth Factor Receptors.- 3 Signaling from TGF-? Receptors.- 4 The Wnt Signal Transduction Pathway.- 5 Signaling from G-Protein-Coupled Receptors to the Nucleus.- 6 Proximal Events in T-Cell Activation.- 7 Signal Transduction from the High Affinity IgE Receptor.- 8 Signaling Through Fas (CD95, APO-1) and Related Death Receptors.- 9 Signal Transduction to the Nucleus by MAP Kinase.- 10 The Regulation of MAP Kinase Pathways by MAP Kinase Phosphatases.- 11 Control of MAPK Signaling by Ste20- and Stel 1-Like Kinases.- 12 Ras Signaling and Transformation.- 13 Signaling Pathways Controlled by Rho Family GTP-Binding Proteins.- 14 PI3-Kinases: Role in Signal Transduction.- 15 PI3K-Related Kinases: Roles in Cell-Cycle Regulation and DNA Damage Responses.- 16 Integrative Signaling Through c-Abl: A Tyrosine Kinase with Nuclear and Cytoplasmic Functions.- 17 Src: A Model for Regulation of Intracellular Signaling Molecules.- 18 Inhibitors of Protein Kinase C and Related Receptors for the Lipophilic Second Messenger sn-1,2-Diacylglycerol.- 19 Reactive Oxygen Species in Proliferative Signaling.- 20 Sphingolipid Metabolites in Signal Transduction.- 21 The Jak/Stat Signaling Cascade: Its Role in the Biological Effects of Interferons.- 22 Regulation of Cell Growth and Death by p53.- 23 Regulation of NF-?B Function: Novel Molecular Targets for Pharmacological Intervention.- 24 Using Protein—Interaction Domains to Manipulate Signaling Pathways.- 25 Protein Tyrosine Kinase Inhibitors as Novel Therapeutic Agents.- 26 A Pharmacological Approach to the MAP Kinase Cascade.- 27 Specific Inhibitors of p38 MAP Kinase.- 28 Farnesyltransferase Inhibitors: Anti-Ras or Anticancer Drugs?.- 29 Targeted p53 Gene Therapy-MediatedRadiosensitization and Chemosensitization.- 30 Treatment of p53-Deficient Cancers by Adenovirus E1B-Region Mutants: From Basic Research to the Clinic.- 31 The Cell Cycle Inhibitor p27 as a Prognostic Marker in Human Tumors and a Novel Target for Therapeutic Intervention.- 32 Chemical Cyclin-Dependent Kinase Inhibitors: Therapeutic Implications.